TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLS

MA45623AUndetermined Publication Date: 2019-05-15JANSSEN BIOTECH INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA45623
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2016-07-05
Filing Date: 2017-06-28
Publication Date: 2019-05-15

Application Information

Patent Timeline

05 Jul 2016

Priority

28 Jun 2017

Application

MA45623

15 May 2019

Publication

MA45623A

IPC: A61K35/51

CPC: A61K35/51; A61P9/10; A61P27/02; A61P43/00; A61K9/0048; C12N5/0605

Inventors: DEJNEKA Nadine Sophia; HARRIS Ian

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to methods and compositions for treating an ophthalmic disease, reducing retinal neovascularization and retinal vascular leakage using progenitor cells, such as postpartum-derived cells, and a conditioned medium from the cells.

Need to check novelty before this filing date? Find Prior Art